Navigation Links
Common orchid gives scientists hope in face of climate change
Date:8/10/2010

A study led by scientists from the Royal Botanic Gardens, Kew's Jodrell Laboratory, which focuses on epigenetics in European common marsh orchids, has revealed that some plants may be able to adapt more quickly to environmental change than previously thought. The new study, published in Molecular Biology and Evolution, brings new hope to plant conservation.

Epigenetics comprises hidden influences upon gene functions that occur without a change in the DNA sequence, but are potentially inheritable, and it is a new field of research that is reshaping the way scientists look at the living world. This new evidence that environmental effects on gene activity can be 'remembered' is hugely significant. In the modern interpretation of Darwin's theory of evolution, scientists previously thought that genetic mutations (permanent changes in DNA sequence) were the only source of new traits that could be handed down from generation to generation, causing changes to the way species react to their environment. This process of adaptation can take hundreds of years and is almost certainly too slow for plants to adapt to rapid climate change.

However, in this cutting-edge study on a group of marsh orchids, Kew scientists have found that epigenetic variation can significantly influence the adaptive potential of an individual species. In turn, this affects the evolutionary potential of a species at a much quicker rate than was previously thought.

This study focused on three recently formed species of delicate purple European marsh-orchids (Dactylorhiza) of hybrid origin, two of them occurring in the UK.(1). Despite having a highly similar genetic heritage, the three orchids differ considerably in ecological requirements, morphology, physical characteristics and distribution.

Dr Ovidiu Paun, lead researcher says, "In contrast to the genetic information, which is a more "closed" system, the environment can alter the epigenetic context of individual species, and this adaptive pathway is complementary to the currently accepted view on evolution. The results in the paper demonstrate that Darwinian selection acts on epigenetic variation in the same way as on the genetic information to result in adaptation and divergence between species within a small number of generations."

He continues, "Our results show the importance of the environment in altering inherited traits in these orchids and also contributing to biodiversity. The epigenetic level of natural variation can be adaptive and has the potential to be rapidly released, in a few generations, in contrast to genetic variation."

Adds Professor Mark Chase, Keeper of Kew's Jodrell Laboratory," Our results are particularly relevant in the present context of widespread environmental challenges and give us more hope in the adaptive potential of organisms. It is not instantaneous, but it is much faster than what we thought previously.

"However, this also means that ex-situ conservation of threatened species, when individuals are removed from their original environment and are usually relocated to a botanical garden, is not the best strategy for their preservation, as it may delete any intrinsic epigenetic specificity. A much better solution remains their conservation in the wild."


'/>"/>

Contact: Bryony Phillips
b.phillips@kew.org
020-833-25607
Royal Botanic Gardens Kew
Source:Eurekalert

Related biology news :

1. Pancreatic cancers use fructose, common in the Western diet, to fuel their growth
2. Rare and common genetic variations responsible for high triglyceride levels in blood
3. Heat waves could be commonplace in the US by 2039, Stanford study finds
4. New rust resistance genes added to common beans
5. Little brown balls tie malaria and algae to common ancestor: UBC research
6. E. coli 0157:H7 present but not common in wildlife of nations salad bowl
7. Immune evasion common in many viruses, bacteria and parasites is uncommon in M. tuberculosis
8. U of Minn. study finds rising levels of dioxins from common soap ingredient in Mississippi River
9. Home medication errors common among children with chronic conditions
10. Southwest Bancorp, Inc. Announces Pricing of $50 Million Underwritten Public Offering of Common Shares
11. The PMI Group, Inc. Announces Pricing of Common Stock and Convertible Senior Notes Offerings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/4/2017)... YORK , April 4, 2017   EyeLock ... today announced that the United States Patent and Trademark ... patent broadly covers the linking of an iris image ... same transaction) and represents the company,s 45 th ... latest patent is very timely given the multi-modal biometric ...
(Date:3/30/2017)... NEW YORK , March 30, 2017 ... by type (physiological and behavioral), by technology (fingerprint, AFIS, ... recognition, voice recognition, and others), by end use industry ... travel and immigration, financial and banking, and others), and ... Europe , Asia Pacific ...
(Date:3/24/2017)... The Controller General of Immigration from Maldives Mr. ... have received the prestigious international IAIR Award for the most innovative ... ... Maldives Immigration ... Algeen (small picture on the right) have received the IAIR award for ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... (PRWEB) , ... October 12, ... ... today announces publication of a United States multicenter, prospective clinical study that ... disposable, point-of-care diagnostic test capable of identifying clinically significant acute bacterial and ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity of ... performing systematic gain-of-function studies. , This complement to loss-of-function studies, such as ...
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
Breaking Biology Technology: